Fatty acid 2-hydroxylase (FA2H), catalyzing the hydroxylation of fatty acids, has been found to be significantly enriched in a subpopulation of ESCC cells with high metastatic potential, and that FA2H inhibition significantly blocks metastatic potential of ESCC cells. Here, FA2H is linked to esophageal squamous cell carcinoma.